Project/Area Number |
17K15753
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Medical sociology
|
Research Institution | Kurume University |
Principal Investigator |
|
Project Period (FY) |
2017-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2018: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2017: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Keywords | 吸入アドヒアランス / 気管支喘息 / 慢性閉塞性肺疾患 / 内服アドヒアランス / COPD / 高齢者 |
Outline of Final Research Achievements |
Inhaled medicines plays a central role in the treatment of bronchial asthma (asthma) and chronic obstructive pulmonary disease (COPD). However, inhalation medicines differs from oral medicines, and there are many different devices, and it is nessesary to understanding of their handling, techniques and dosages. The complexity of inhaled medicines leads to reduced adherence, and then which may lead to reduced levels of disease control and wasted medical costs. This study will elucidate the reality of inhaled medicines adherence in patients with asthma and COPD. And we aim to build a system to enlighten inhaled medicines.
|
Academic Significance and Societal Importance of the Research Achievements |
日本人のCOPDとぜん息患者の吸入薬アドヒアランスに対する障壁をASK-20質問表を用いて検討した。その結果、経口薬に対して吸入薬の独立したアドヒアランスバリアは、同じ吸入薬を使用するCOPDとぜん息患者ではそのアドヒアランスに対する障壁の内容が異なった。今回のこれらの結果は、吸入薬アドヒアランスにおける障害因子の特定化や患者の個別教育に役立つと考えられた。本システムの構築がなされれば、吸入薬アドヒアランスの更なる向上が望め、医療費の無駄を削減できると考えている。
|